About Prime Medicine, Inc. 
Prime Medicine, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 38 Schemes (18.94%)
Foreign Institutions
Held by 66 Foreign Institutions (7.35%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Dec 2025)
Net Profit:
-46 Million
Pharmaceuticals & Biotechnology
USD 590 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.27
-121.92%
3.65






